Acupuncture inhibits microglial activation and inflammatory events in the MPTP-induced mouse model

被引:100
作者
Kang, Jun Mo
Park, Hi Joon
Choi, Yeong Gon
Choe, Il Hwan
Park, Jae Hyun
Kim, Yong Sik
Lim, Sabina [1 ]
机构
[1] Kyung Hee Univ, Coll Korean Med, Dept Meridian & Acupoints, Seoul, South Korea
[2] Kyung Hee Univ, WHO Collaborating Ctr Tradit Med, EW Med Res Inst, Seoul, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Pharmacol, Seoul, South Korea
关键词
acupuncture; Parkinson's disease; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; microglial activation; cyclooxygenase-2; inducible nitric oxide synthase;
D O I
10.1016/j.brainres.2006.10.089
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Using a mouse model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson's disease (PD), this study investigated on the neuroprotective effects of acupuncture by examining whether acupuncture contributed to inhibiting microglial activation and inflammatory events. C57BL/6 mice were treated with MPTP (30 mg/kg, i.p.) for 5 consecutive days. Acupuncture was then applied to acupoints Yanglingquan (GB34) and Taichong (LR3) starting 2 h after the first MPTP administration and then at 48 h intervals until the mice were sacrificed for analyses at 1, 3, and 7 days after the last MPTP injection. These experiments demonstrated that acupuncture inhibited the decreased of the tyrosine hydroxylase (TH) immunoreactivity (IR) and generated a neuroprotective effects in the striatum (ST) and the substantia nigra (SN) on days 1, 3, and 7 post-MPTP injections. Acupuncture attenuated the increase of macrophage antigen complex-1 (MAC-1), a marker of microglial activation, at 1 and 3 days and reduced the increases in cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) expression on days 1, 3, and 7. In MPTP group, striatal dopamine (DA) was measured by 46% at 7 days, whereas DA in the acupuncture group was 78%. On the basis of these results, we suggest that acupuncture could be used as a neuroprotective intervention for the purpose of inhibiting microglial activation and inflammatory events in PD. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:211 / 219
页数:9
相关论文
共 28 条
[1]   Animal models of Parkinson's disease [J].
Betarbet, R ;
Sherer, TB ;
Greenamyre, JT .
BIOESSAYS, 2002, 24 (04) :308-318
[2]   Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease [J].
Blum, D ;
Torch, S ;
Lambeng, N ;
Nissou, MF ;
Benabid, AL ;
Sadoul, R ;
Verna, JM .
PROGRESS IN NEUROBIOLOGY, 2001, 65 (02) :135-172
[3]   Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson's disease mice model [J].
Czlonkowska, A ;
Kohutnicka, M ;
Kurkowska-Jastrzebska, I ;
Czlonkowski, A .
NEURODEGENERATION, 1996, 5 (02) :137-143
[4]   Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo [J].
Dehmer, T ;
Lindenau, J ;
Haid, S ;
Dichgans, J ;
Schulz, JB .
JOURNAL OF NEUROCHEMISTRY, 2000, 74 (05) :2213-2216
[5]   Genetic ablation of tumor necrosis factor-alpha (TNF-α) and pharmacological inhibition of TNF-synthesis attenuates MPTP toxicity in mouse striatum [J].
Ferger, B ;
Leng, A ;
Mura, A ;
Hengerer, B ;
Feldon, J .
JOURNAL OF NEUROCHEMISTRY, 2004, 89 (04) :822-833
[6]   MICROGLIA - INTRINSIC IMMUNEFFECTOR CELL OF THE BRAIN [J].
GEHRMANN, J ;
MATSUMOTO, Y ;
KREUTZBERG, GW .
BRAIN RESEARCH REVIEWS, 1995, 20 (03) :269-287
[7]   Regulation of Dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease [J].
Hayley, S ;
Crocker, SJ ;
Smith, PD ;
Shree, T ;
Jackson-Lewis, V ;
Przedborski, S ;
Mount, M ;
Slack, R ;
Anisman, H ;
Park, DS .
JOURNAL OF NEUROSCIENCE, 2004, 24 (08) :2045-2053
[8]   MELANIZED DOPAMINERGIC-NEURONS ARE DIFFERENTIALLY SUSCEPTIBLE TO DEGENERATION IN PARKINSONS-DISEASE [J].
HIRSCH, E ;
GRAYBIEL, AM ;
AGID, YA .
NATURE, 1988, 334 (6180) :345-348
[9]   Glial cells and inflammation in Parkinson's disease: A role in neurodegeneration? [J].
Hirsch, EC ;
Hunot, S ;
Damier, P ;
Faucheux, B .
ANNALS OF NEUROLOGY, 1998, 44 (03) :S115-S120
[10]   Nitric oxide synthase and neuronal vulnerability in Parkinson's disease [J].
Hunot, S ;
Boissiere, F ;
Faucheux, B ;
Brugg, B ;
MouattPrigent, A ;
Agid, Y ;
Hirsch, EC .
NEUROSCIENCE, 1996, 72 (02) :355-363